Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.

A vaccine being injected into a woman's upper arm

I supported with the recruitment process of participants in the COVID-19 Phase II/III Vaccine Study as a Research Nurse. The trial is jointly run by the Oxford Vaccine Group (Department of Paediatrics) and Jenner Vaccine Trials team (Nuffield Department of Medicine) at the Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital. 

Many people volunteered for the study and many healthcare workers were required to help. Jane NiedererKatherine Gordan-Quayle and I initially helped with screening, ensuring that participants were eligible and safe to take part. The study visits included gaining informed consent, which was ongoing as the protocol developed, and taking bloods samples. Other responsibilities included preparation of the blinded vaccine and observation of participants post vaccination. 

Participants' appointments were back-to-back. Each participant had different requirements depending on the arm or group they were allocated to, so we all had to be meticulous and vigilant! Recruitment completed in early December 2020 and participants will be followed up to a year after vaccination, which I will continue to help with. It was a huge combined effort of many teams, from medical students to lab and admin staff, to make this vaccine possible. 

It was very exciting to put my research experience and skills to use during the first lockdown and I will continue to work on the new upcoming COVID-19 trials

Medicines from clinical trials usually take many years to become licenced. Personally, it was truly amazing to see the analysis as the study rolled out and to receive the Oxford-Astra-Zeneca COVID-19 vaccine myself! 

I couldn't work as a front-line nurse, so it was very exciting to put my research experience and skills to use during the first lockdown and I will continue to work on the new upcoming COVID-19 trials with the Oxford Vaccine Group in 2021.  

Bhumika has recently started a new position as Clinical Research Nurse at the Oxford Respiratory Trials Unit.

Blog posts

Why I became a Peer Supporter

The Peer Support Programme was developed in recognition of the essential role students play in supporting and encouraging one another on a day-to-day basis throughout their time at university. NDS’ own Helen Stark discusses her experience of becoming a Peer Supporter.

Racism under the microscope

As Black History Month gets underway in the UK, NDS Athena SWAN Coordinator Emily Hotine puts racism under the microscope.

In memory of Sue Bonnington

Pete Holding shares his memories of a much-loved colleague, Sue Bonnington. Based in Leicester, Sue worked remotely for the Nuffield Department of Surgical Sciences (NDS) as a ProtecT study Lead Research Nurse from 2002 to 2017.

Hosting a virtual work experience programme

In this blog post, Dr Hannah McGivern, a Tissue Handling Technician for the Quality in Organ Donation (QUOD) initiative at NDS, discusses her involvement in the NDS Virtual Work Experience Programme, and shares how fascinating and rewarding it was to talk with the students about a career in research.

SITU Work Experience 2020

Lucy Paterson (NDS) and Teya Agnese (NDORMS) from the Surgical Intervention Trials Unit (SITU) describe the fun challenge of delivering an online SITU session to this year's NDS work experience students.

Similar stories

Reflections on gratitude during lockdown

Louise King collates our words of gratitude amid the COVID-19 pandemic.